Acta Neuropathologica Communications
Peptide improved movement in mouse models of brain disease
Daily injections from 3 to 12 months of age improved movement and behavior in male and female mice modeling Huntington’s disease.Daily injections from 3 to 12 months of age improved movement and behavior in male and female mice modeling Huntington’s disease.
Mouse studyInterventions
Who was studiedZQ175 heterozygous mice, against vehicle-treated zQ175 mice
What changedPeptide-treated Huntington’s-model mice made fewer missteps than vehicle-treated mice
The catchMovement benefits from starting treatment after symptoms were not measured